Applied Biosystems' Good Genes Boost Stock 56% In 2000; Index Ahead 29%

The untapped possibilities of genetic analysis for early stage detection of disease combined with a nearly completed effort to map the human genome helped breathe new life into the diagnostics sector in 2000, led by Applera Corp. (formerly PE Corp.) and its two component business units, Applied Biosystems and Celera Genomics.